SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-20-000055
Filing Date
2020-03-17
Accepted
2020-03-17 07:31:04
Documents
5
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq1moleculinutmbcoll.htm 8-K 22049
2 EXHIBIT 1.1 exh11-mrestandardmoleculin.htm EX-1.1 34865
3 EXHIBIT 99.1 exh991-pressreleasemolecul.htm EX-99.1 15739
4 moleculin-logo_horiza27.jpg GRAPHIC 132868
5 moleculinlogoa34.jpg GRAPHIC 11658
  Complete submission text file 0001659617-20-000055.txt   262417
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 20719255
SIC: 2834 Pharmaceutical Preparations